Saturday, July 24

Moderna confronts a $100 billion question



Hello,

Welcome to Insider Healthcare. I’m Zachary Tracer, and today in healthcare news:

  • We examined Moderna’s transformation, and what comes next;
  • The head of the FDA is calling for a probe of her agency’s decision to approve Aduhelm;
  • Wondering if you’ve got COVID or the common cold? This chart might help.

If you’re new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @ztracer. Let’s get to it…


Scientists at Moderna's research hub in Norwood, Massachusetts working on the biotech's mRNA technology

Scientists at Moderna’s research hub in Norwood, Massachusetts working on the biotech’s mRNA technology.

Franco Sacchi/Insider


We got an exclusive look inside Moderna’s labs, where the biotech upstart is planning what comes after its blockbuster coronavirus vaccine

  • Led by its coronavirus vaccine, Moderna has surged into the drug industry’s top ranks.
  • The biotech has rapidly expanded to boost production by hiring hundreds and opening new buildings.
  • Insider visited Moderna’s labs to learn about the biotech’s plans beyond COVID-19.

See what’s next>>


Janet Woodcock

Interim FDA Commission Janet Woodcock.

Tom Williams/Getty Images


The head of the FDA is calling for an investigation into her agency’s controversial decision to approve a new Alzheimer’s drug

  • Interim FDA Commissioner Janet Woodcock has asked for an outside investigation into an Alzheimer’s drug approval.
  • The agency approved the drug, Aduhelm, last month, despite a lack of evidence showing the drug slowed the disease.
  • Officials from Biogen and the FDA worked closely together to revive the drug, raising concerns.

Read more>>


coronavirus test

A medical worker performs a PCR test for COVID-19.

Alain Jocard/AFP/Getty Images


COVID-19 symptoms are overlapping again with colds, flu, and seasonal allergies. Here’s how to tell the difference.

  • Respiratory infections may become more prevalent again now that Americans are ditching their masks.
  • Some cold or flu cases could be easily confused with a mild COVID-19 infection.
  • Headaches and runny noses seem to be more common among recent COVID-19 cases than past ones.

Learn the symptoms to watch for>>


More stories we’re reading:


-Zach





www.businessinsider.com

Leave a Reply

Your email address will not be published. Required fields are marked *